ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC15.5

C15.5

Billable

Malignant neoplasm of lower third of esophagus

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C15.5 is a billable code used to indicate a diagnosis of malignant neoplasm of lower third of esophagus.

Key Diagnostic Point:

C15.5 refers to a malignant neoplasm located in the lower third of the esophagus, which is a critical area for esophageal cancer. This type of cancer often presents with symptoms such as dysphagia (difficulty swallowing), weight loss, and chest pain. The lower third of the esophagus is particularly significant as it is where the esophagus connects to the stomach, making it susceptible to both local invasion and metastasis. Staging of esophageal cancer is crucial for determining treatment options and prognosis. The American Joint Committee on Cancer (AJCC) staging system is commonly used, which includes T (tumor size and extent), N (lymph node involvement), and M (metastasis). Surgical approaches may include esophagectomy, which is the removal of part or all of the esophagus, often accompanied by reconstruction of the digestive tract. Post-surgical management is essential, as patients may experience changes in swallowing function, necessitating dietary modifications and possibly rehabilitation. Accurate coding of this condition is vital for appropriate treatment planning and reimbursement.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Variability in staging and treatment options
  • Need for precise documentation of tumor location and extent
  • Potential for multiple co-morbid conditions affecting treatment
  • Complex surgical procedures and their coding

Audit Risk Factors

  • Inadequate documentation of staging
  • Failure to capture all relevant procedures performed
  • Misclassification of tumor location
  • Inconsistent documentation of patient symptoms

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans must be documented.

Common Clinical Scenarios

Patients presenting with dysphagia, weight loss, or post-operative complications.

Billing Considerations

Ensure accurate staging and documentation of any neoadjuvant therapies.

Gastroenterology

Documentation Requirements

Endoscopy reports, biopsy results, and any imaging studies must be included.

Common Clinical Scenarios

Patients undergoing surveillance for esophageal cancer or presenting with gastrointestinal symptoms.

Billing Considerations

Document any findings related to Barrett's esophagus or dysplasia.

Coding Guidelines

Inclusion Criteria

Use C15.5 When
  • According to ICD
  • CM guidelines, C15
  • 5 should be used when the documentation specifies a malignant neoplasm located in the lower third of the esophagus
  • It is important to ensure that the diagnosis is confirmed by pathology and that staging is documented

Exclusion Criteria

Do NOT use C15.5 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

43121CPT Code

Esophagectomy

Clinical Scenario

Used for surgical treatment of C15.5.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Oncology and surgery specialties must coordinate documentation.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of esophageal cancers, improving the accuracy of data collection and reimbursement processes. C15.5 provides a clear distinction for malignant neoplasms in the lower third, which was less specific in ICD-9.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of esophageal cancers, improving the accuracy of data collection and reimbursement processes. C15.5 provides a clear distinction for malignant neoplasms in the lower third, which was less specific in ICD-9.

Reimbursement & Billing Impact

reimbursement processes. C15.5 provides a clear distinction for malignant neoplasms in the lower third, which was less specific in ICD-9.

Resources

Clinical References

  • •
    American Cancer Society - Esophageal Cancer

Coding & Billing References

  • •
    American Cancer Society - Esophageal Cancer

Frequently Asked Questions

What is the significance of staging in C15.5?

Staging is crucial as it determines the treatment approach and prognosis. Accurate documentation of the stage is necessary for coding and treatment planning.